RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease

Author： Hudson Barry I.   Schmidt Ann Marie  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.7, 2004-07, pp. : 1079-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy

By  

Current Drug Targets, Vol. 11, Iss. 11, 2010-01 ,pp. : 1468-1482

Bentham Science Publishers

Access to resources Recommend Favorite

CCN2: a novel, specific and valid target for anti-fibrotic drug intervention

By Leask Andrew  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1067-1071

Informa Healthcare

Access to resources Recommend Favorite

Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 447-452

Bentham Science Publishers

Access to resources Recommend Favorite

Ectopic calcification in diabetic vascular disease

By Avogaro Angelo   Rattazzi Marcello   Fadini Gian Paolo  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 595-609

Informa Healthcare

Access to resources Recommend Favorite